drug

TNG462

1 story · latest Oct 27, 2026

Follow TNG462. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Tango Therapeutics, Inc.

Timeline

Tango registers Phase 1/2 trial pairing vopimetostat with Erasca's ERAS-0015

Oct 27Trial updateERAS-0015 Erasca, Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.